DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01700 E1P49 WKVPFDFWRGVISLTPLL HIV 26905802
DRAVPe01701 E1P49-1 KVPFDFWRGVISLTPLLV HIV 26905802
DRAVPe01702 E1P49-2 VPFDFWRGVISLTPLLVC HIV 26905802
DRAVPe01703 E1P50 PFDFWRGVISLTPLLVCV HIV 26905802
DRAVPe01704 E1P50-1 FDFWRGVISLTPLLVCVA HIV 26905802
DRAVPe01705 E1P50-2 DFWRGVISLTPLLVCVAA HIV 26905802
DRAVPe01706 E1P51 FWRGVISLTPLLVCVAAL HIV 26905802
DRAVPe01707 E1P51-1 WRGVISLTPLLVCVAALL HIV 26905802
DRAVPe01708 E1P51-2 RGVISLTPLLVCVAALLL HIV 26905802
DRAVPe01709 E1P52 GVISLTPLLVCVAALLLL HIV 26905802
DRAVPe01710 E1P52-1 VISLTPLLVCVAALLLLE HIV 26905802
DRAVPe01711 E1P52-2 ISLTPLLVCVAALLLLEQ HIV 26905802
DRAVPe01751 T21N17 RIQQIEQKIHHIEQRIQQIEQLLQLTVWGIKQLQARIL HIV-1 31932193
DRAVPe01752 T21N23 RIQQIEQKIHHIEQRIQQIEQRAIEAQQHLLQLTVWGIKQLQARIL HIV-1 31932193
DRAVPe01753 T21N36 RIQQIEQKIHHIEQRIQQIEQRISGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL HIV-1 31932193
DRAVPe01797 C8 WEDWVRWI FIV 30240422
DRAVPe01798 C6a DWVRWI FIV 30240422
DRAVPe01799 C6b WEDWVR FIV 30240422
DRAVPe01809 Kn2-7 FIKRIARLLRKIF HIV 22536342
DRAVPe01878 Pep19-2.5 GCKKYRRFRWKFKGKFWFWG HIV, HSV-1, HCV, HBV 22457281
DRAVPe01879 Pep19-4 GKKYRRFRWKFKFGKWFWFG HIV, HSV-1, HCV 22457281
DRAVPe01956 Dermaseptin-4 ALWMTLLKKVLKAAAKAALNAVLVGANA HIV 15780876
DRAVPe01957 Dermaseptin S4 (1-16)[M4K] ALWKTLLKKVLKAAAK HIV 15780876
DRAVPe01958 Beta-defensin 2(BD-2, hBD-2, SAP1) GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP HIV 16254366
DRAVPe01959 Cicadin NEYHGFVDKANNENKRKKQQGRDDFVVKPNNFANRRRKDDYNENYYDDVDAADVV HIV 11814612
DRAVPe01960 Leaf cyclotide, Vhl-1 CGESCAXISFCFTEVIGCSCKNKVCYLNSIS HIV 15824119
DRAVPe01973 CHR-1, Env GP (623-658) WNHTTWMEWDREINNYTSLIHSLIEESQNQQEKNEQ HIV 17276993
DRAVPe01974 C36, Env GP (628-663) WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLEL HIV 17276993
DRAVPe01975 CHR-3, Env GP (633-668) REINNYTSLIHSLIEESQNQQEKNEQELLELDKWAS HIV 17276993
DRAVPe01976 CHR-5, Env GP (643-678) HSLIEESQNQQEKNEQELLELDKWASLWNWFNITNW HIV 17276993
First 24 25 26 27 28 29 30 Last